Your Article Summary
See Latest ArticlesThe role of difluprednate ophthalmic emulsion in clinical practice
Clinical Ophthalmology, 06/30/09
Jamal KN et al. - In vivo pharmacokinetics as well as ocular distribution and metabolism are discussed, followed by a comprehensive summary of phase I, II, and III clinical trials evaluating safety and efficacy in patients suffering from postoperative inflammation or anterior uveitis. The objective is to provide an increased familiarity with this newly approved medication as a welcome addition to the ophthalmologist's armamentarium.
Related Articles
Tubulointerstitial nephritis and uveitis syndrome
Current Opinion in Ophthalmology, 10/27/09
Relevance Score: 89%
Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/02/09
Relevance Score: 89%
Cataract Surgery Under Infliximab Therapy in a Patient With Behcet's Disease
Journal of Ocular Pharmacology and Therapeutics, 10/30/09
Relevance Score: 87%
Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin
Eye, 10/26/09
Relevance Score: 87%
General Principles for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets, 10/09/09
Relevance Score: 87%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
Medicinal Research Reviews, 12/09/09
Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol
Therapeutics and Clinical Risk Management, 12/09/09
Pharmacotherapy of diabetic foot osteomyelitis
Expert Opinion in Pharmacotherapy, 12/09/09
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
British Journal of Clinical Pharmacology, 12/09/09
Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers
Current Medical Research and Opinion, 12/08/09
Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09